4//SEC Filing
Estepan Ian Michael 4
Accession 0000950170-25-011959
CIK 0000873303other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 8:30 PM ET
Size
11.8 KB
Accession
0000950170-25-011959
Insider Transaction Report
Form 4
Estepan Ian Michael
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-01-29$12.00/sh+14,267$171,204→ 47,963 total - Tax Payment
Common Stock
2025-01-29$117.51/sh−2,613$307,054→ 46,883 total - Exercise/Conversion
Common Stock
2025-01-29$12.00/sh+1,533$18,396→ 49,496 total - Exercise/Conversion
Stock Option (right to buy)
2025-01-29−14,267→ 0 totalExercise: $12.00From: 2016-01-30Exp: 2025-01-30→ Common Stock (14,267 underlying) - Exercise/Conversion
Stock Option (right to buy)
2025-01-29−1,533→ 0 totalExercise: $12.00From: 2016-01-30Exp: 2025-01-30→ Common Stock (1,533 underlying)
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy tax witholding obligations and payment by the Reporting Person of the option exercise price. The Reporting Person holds the exercised shares not withheld by the Issuer.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001836254
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 8:30 PM ET
- Size
- 11.8 KB